NeoGenomics launches blood-based cancer test PanTracer LBx
Go back to NeoGenomics launches blood-based cancer test PanTracer LBx| NEOGENOMICS (NASDAQ: NEO) | Delayed: 17.46 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.46 | 52 Week High | $9.54 | |||
| Open | $17.46 | 52 Week Low | $5.49 | |||
| Day High | $17.46 | P/E | 436.50 | |||
| Day Low | $17.46 | EPS | $0.04 | |||
| Volume | 5,491 | |||||

